Bal Pharma Limited (BALPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 961.16M |
| Enterprise Value | 2.48B |
| P/E Ratio | 23.41 |
| PEG Ratio | -3.78 |
| Price/Sales Ratio | 0.51 |
| Price/Book Ratio | 2.06 |
| Enterprise/Revenue | 0.51 |
| Enterprise/EBITDA | 4.88 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 3.12B |
| Revenue/Share | 210.04 |
| Gross Profit | 761.52M |
| EBITDA | 338.31M |
| Net Income | 62.84M |
| Diluted EPS | 3.95 |
Balance Sheet
| Total Cash | 92.92M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 51.66 |
Price History
| 52-Week Change | 27.32 |
| 52-Week High | 124.6 |
| 52-Week Low | 60 |
| Moving Average 50 Days | 93.32 |
| Moving Average 200 Days | 80.71 |
Statistics
| Average Volume | 76,730 |
| Shares Outstanding | 15.92M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.2 |
| Trailing Annual Dividend Yield | 1.13 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
